Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hunter C Champion

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Rheumatic Diseases Clinics of North America|March 11, 2008
The heart in sclerodermaHunter C Champion
The American Journal of Cardiology|April 6, 2013
When to initiate intravenous therapy and/or referHunter C Champion
Circulation Research|April 16, 2005
Targeting protein phosphatase 1 in heart failureHunter C Champion
Current Cardiology Reports|May 2, 2007
Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategiesMobusher Mahmud, Hunter C Champion
Expert Review of Cardiovascular Therapy|May 24, 2006
Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertensionAnna R Hemnes, Hunter C Champion
Expert Opinion on Therapeutic Targets|January 24, 2003
Emerging therapeutic targets in nitric oxide-dependent cardiac diseaseHunter C Champion, Joshua M Hare
Nature Medicine|March 3, 2004
Calcium handler mishandles heartHunter C Champion, David A Kass
Circulation|February 29, 2012
Toward systems biology of pulmonary hypertensionFerhaan Ahmad, Hunter C Champion, Naftali Kaminski
International Journal of Cardiology|February 11, 2014
"Happiness" and stress cardiomyopathy (apical ballooning syndrome/takotsubo syndrome)Dingxin Qin, Sandeep M Patel, Hunter C Champion
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 30, 2007
PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activationAnna R Hemnes, Ari Zaiman, Hunter C Champion
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Rheumatic Diseases Clinics of North America|March 11, 2008
The heart in sclerodermaHunter C Champion
The American Journal of Cardiology|April 6, 2013
When to initiate intravenous therapy and/or referHunter C Champion
Circulation Research|April 16, 2005
Targeting protein phosphatase 1 in heart failureHunter C Champion
Current Cardiology Reports|May 2, 2007
Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategiesMobusher Mahmud, Hunter C Champion
Expert Review of Cardiovascular Therapy|May 24, 2006
Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertensionAnna R Hemnes, Hunter C Champion
Expert Opinion on Therapeutic Targets|January 24, 2003
Emerging therapeutic targets in nitric oxide-dependent cardiac diseaseHunter C Champion, Joshua M Hare
Nature Medicine|March 3, 2004
Calcium handler mishandles heartHunter C Champion, David A Kass
Circulation|February 29, 2012
Toward systems biology of pulmonary hypertensionFerhaan Ahmad, Hunter C Champion, Naftali Kaminski
International Journal of Cardiology|February 11, 2014
"Happiness" and stress cardiomyopathy (apical ballooning syndrome/takotsubo syndrome)Dingxin Qin, Sandeep M Patel, Hunter C Champion
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 30, 2007
PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activationAnna R Hemnes, Ari Zaiman, Hunter C Champion
Pageof 16